NEW YORK (GenomeWeb News) – Agilent Technologies today reported a 9 percent drop in fourth-quarter revenues for its Bioanalytical segment, including a 7 percent dip in life science receipts.

The slowing sales in Agilent's Bioanalytical segment contributed to an overall 21 percent drop in company-wide Q4 revenues and an 89 percent decline in net income.

For the fourth quarter ended Oct. 31, 2009, Agilent's Bioanalytical group reported revenues of $544 million compared to $594 million for Q4 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.